Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Organic Chemistry >  Heterocyclic Compounds >  2,6-DICHLORO-N-METHYL-4-PYRIMIDINAMINE

2,6-DICHLORO-N-METHYL-4-PYRIMIDINAMINE

Basic information Safety Supplier Related

2,6-DICHLORO-N-METHYL-4-PYRIMIDINAMINE Basic information

Product Name:
2,6-DICHLORO-N-METHYL-4-PYRIMIDINAMINE
Synonyms:
  • 2,6-DICHLORO-N-METHYL-4-PYRIMIDINAMINE
  • 4-Pyrimidinamine, 2,6-dichloro-N-methyl-
CAS:
32998-03-1
MF:
C5H5Cl2N3
MW:
178.02
Mol File:
32998-03-1.mol
More
Less

2,6-DICHLORO-N-METHYL-4-PYRIMIDINAMINE Chemical Properties

Melting point:
186 °C
Boiling point:
314.7±22.0 °C(Predicted)
Density 
1.492±0.06 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2–8 °C
pka
-0.77±0.10(Predicted)
Appearance
White to off-white Solid
More
Less

2,6-DICHLORO-N-METHYL-4-PYRIMIDINAMINE Usage And Synthesis

Synthesis

3764-01-0

74-89-5

10397-15-6

32998-03-1

The general procedure for the synthesis of 4,6-dichloro-N-methylpyrimidin-2-amine and 2,6-dichloro-N-methylpyrimidin-4-amine from 2,4,6-trichloropyrimidine (0.50 g, 2.7 mmol) and monomethylamine (2 M THF solution, 3.0 mL, 6.0 mmol) was as follows: 2,4,6-trichloropyrimidine was dissolved in THF (3 mL), followed by dropwise THF solution of monomethylamine was added. The reaction mixture was slowly warmed to room temperature and stirred continuously for 30 min, and the formation of the target product was confirmed by LCMS monitoring. Upon completion of the reaction, the reaction was quenched with deionized water (10 mL) and extracted with ethyl acetate (2 × 10 mL). The organic phases were combined, washed with saturated saline (10 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (eluent: hexane/ethyl acetate gradient, 0-30% ethyl acetate) to isolate 2,6-dichloro-N-methyl-4-pyrimidinamine (180 mg, 1.01 mmol, 38% yield) and 4,6-dichloro-N-methyl-2-pyrimidinamine (150 mg, 0.85 mmol, 31% yield). The mass spectra (ES+) of both compounds showed m/e 178 [M+H]+.

References

[1] Nucleosides and Nucleotides, 1994, vol. 13, # 8, p. 1769 - 1777
[2] Patent: WO2008/105968, 2008, A1. Location in patent: Page/Page column 66-67
[3] Journal fuer Praktische Chemie (Leipzig), 1927, vol. <2> 115, p. 293
[4] Patent: US9433621, 2016, B2. Location in patent: Page/Page column 113; 114; 115; 116
[5] Patent: WO2010/22121, 2010, A1. Location in patent: Page/Page column 147

2,6-DICHLORO-N-METHYL-4-PYRIMIDINAMINESupplier

Tetranov Biopharm
Tel
13526569071
Email
sales@leadmedpharm.com
Bide Pharmatech Ltd.
Tel
400-164-7117 13681763483
Email
product02@bidepharm.com
Shanghai ChuangYan Chemical Technology Co., Ltd.
Tel
021-11111111 11111111111
Email
546919421@qq.com
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd.
Tel
025-66028182 18626450290
Email
yftan@aikonchem.com
Hangzhou Milestone Pharmtech Co., Ltd.
Tel
0571-82896630 18969958410
Email
sales_hz@milestonepharmtech.com